Synairgen (LON:SNG) Trading Down 17.8% – What’s Next?

Synairgen plc (LON:SNG)’s stock price dropped 17.8% during mid-day trading on Friday . The stock traded as low as GBX 2.10 ($0.03) and last traded at GBX 2.10 ($0.03). Approximately 549,758 shares were traded during trading, an increase of 63% from the average daily volume of 337,550 shares. The stock had previously closed at GBX 2.56 ($0.03).

Synairgen Trading Down 17.8 %

The business has a fifty day moving average price of GBX 4.29 and a 200 day moving average price of GBX 4.30. The firm has a market cap of £4.23 million, a PE ratio of -70.00 and a beta of -2.23. The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09.

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.